- $196.39m
- $200.62m
- $52.84m
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength
Brief: Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter And Full Year 2025 Revenue Results
Brief: Apyx Medical Corporation Announces Approval And Commercial Launch Of Apyx One Console And Single-Use Handpieces
Brief: Apyx Medical Corporation Announces Pricing Of $10 Million Public Offering Of Common Stock
Apyx Medical Q3 revenue beats estimates, ups FY sales outlook
Apyx Medical Corp reports results for the quarter ended June 30 - Earnings Summary
Apyx Medical misses Q2 revenue estimates; raises FY25 guidance
Apyx Medical Corp expected to post a loss of 9 cents a share - Earnings Preview
Apyx Medical Corp reports results for the quarter ended March 31 - Earnings Summary
Apyx Medical Corp expected to post a loss of 12 cents a share - Earnings Preview
Apyx Medical Corp reports results for the quarter ended December 31 - Earnings Summary
Apyx Medical Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
Brief: Apyx Medical Submits 510(K) Premarket Notification To The U.S. FDA For The Ayon Body Contouring System
Apyx Medical Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Apyx Medical Says Entered Into Amendment To Credit Agreement And Guaranty
Brief: Apyx Medical Corp Reports Q3 2024 Results, Updates 2024 Outlook And Introduces 2025 Financial Outlook